ACADM and nonpapillary renal cell carcinoma: Inhibition of ACADM-mediated fatty acid oxidation by Ma et al. promotes hepatocellular carcinoma through the CAV1/SREBP1 signaling pathway [22], but its role in ccRCC requires further study.